顯示第 17 至 32 項結果,共 108 項
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-26.0-BT)
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-26.0)
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-35.0-BT)
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-35.0)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-10.0-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-10.0)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-10.3-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-10.3)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-23.0-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-23.0)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-26.0-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-26.0)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-35.0-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-35.0)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-36.0-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-36.0)
